Pharmaceutical companies should stockpile six weeks’ worth of drugs to limit disruption at the end of the Brexit transition period, the Government has warned.
The Department of Health and Social Care (DHSC) has written to medicine suppliers advising them to make boosting their reserves a priority.
The letter, published online on Monday, reiterates that ministers will not be asking for an extension to the transition period past December 31, despite the coronavirus pandemic.
There are concerns that the Covid-19 crisis has led to a dwindling of some medical stocks and that a disorderly exit without a trade deal could cause significant disruption.
Suppliers were advised all scenarios must be planned for, including reduced traffic flow at short crossings such as between Calais and Dunkirk, and Dover and Folkestone.
“We recognise that global supply